Streamlining your program from early phase development to commercialization, mitigating project risk and producing a quality medicine, Abzena is an industry leader in the development, scaling and manufacture of small molecule intermediates including high potency chemistry, payloads, linkers, payload-linker chemical intermediates, bioconjugation and Antibody Drug Conjugates (ADCs).
Wherever your molecule is in its development, we have the agility and capability to support technology transfer, process optimization, and full process development capabilities.
Proven Track Record
We have a proven track record of producing a wide range of molecules from the most straightforward to very complex modalities:
We are committed to achieving quality excellence. We’re transparent in our communications and work collaboratively to progress your programs.
Our team collaborates with you and uses deep scientific and technical know-how to find the best solutions using the right technologies to deliver your program with a constant commitment to quality.
We adapt our approach, shorten the lead times, and develop risk mitigation strategies to ensure your overall success to get vital medicines to patients.
